1 型,2 型および妊娠糖尿病におけるビタミンD 補給の役割: 総合的な最新の説明レビュー
Asala Nasser1, Dimitrios Papandreou1, Sousana K Papadopoulou2
1Department of Clinical Nutrition, College of Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates.
Clinics and practice
|August 27, 2025
まとめ
ビタミンDは,臓の細胞と炎症に影響を与えることで,糖尿病の管理に影響を与えます. 十分なビタミンDを摂取すると,タイプ1と2と妊娠中の糖尿病の代謝効果が生まれます.
科学分野:
- 内分泌学と代謝
- 栄養学
- 免疫学
背景:
- ビタミンDは 臓のベータ細胞機能,免疫調節,炎症,糖尿病の病原性において重要な役割を果たします.
- ビタミンD欠乏症は流行しており,代謝障害を含む様々な健康問題と関連しています.
研究 の 目的:
- ビタミンD状態と1型糖尿病 (T1DM),2型糖尿病 (T2DM),妊娠糖尿病 (GDM) を関連付けるメカニズム的および臨床的証拠をレビューする.
- 糖尿病の予防と管理のための補助療法としてのビタミンDの可能性を評価する.
主な方法:
- 既存の文献の記述的なレビュー
- 機械学的研究と臨床試験の分析
- ビタミンDレベルと糖尿病の発生率と制御を関連付ける疫学データの検討
主要な成果:
- ビタミンDの不足はT1DMの発生率の低下と血糖コントロールの改善と関連しており,免疫調節効果はベータ細胞を保護する可能性がある.
- T2DMのビタミンD欠乏は代謝制御の低下と相関し,補充はインスリン感受性とベータ細胞機能をわずかに改善する可能性があります.
- 妊婦のビタミンDが低ければ,GDMのリスクが増加し,不良な周産期の結果が生じます.
結論:
- 十分なビタミンDレベルは,T1DM,T2DM,GDMの間で代謝上の利点を提供しているようで,補助療法としての役割を示唆しています.
- 最適なビタミンDサプリメントのプロトコルを確立し,糖尿病の治療における有効性を確認するために,さらなる大規模な試験が必要である.
さらに関連する動画
関連する概念動画
01:22Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
01:22Diabetes Mellitus: Overview and Type I Subtype
3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
01:20Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
01:15Diabetes: Management and Pharmacotherapy
362
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
362
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
291
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
291
01:16Insulin: Dosing Regimen and Adverse Effects
257
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
257